Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
Norman G, Rice S, Spackman E, Stirk L, Danso-Appiah A, Suh D, Palmer S, Eastwood A
Record ID 32013000624
English
Details
Project Status:
Completed
Year Published:
2011
URL for published report:
http://www.hta.ac.uk/erg/supplements/supplement1501.pdf#nameddest=article04
URL for additional information:
http://www.hta.ac.uk/project/2234.asp
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Capecitabine
- Clinical Trials, Phase III as Topic
- Cost-Benefit Analysis
- In Situ Hybridization, Fluorescence
- Meta-Analysis as Topic
- Multicenter Studies as Topic
- Neoplasm Metastasis
- Quality-Adjusted Life Years
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2
- Trastuzumab
- Adenocarcinoma
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents
- Cisplatin
- Deoxycytidine
- Epirubicin
- Esophageal Neoplasms
- Fluorouracil
- Stomach Neoplasms
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2011 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.